Rating Change
Cantor Fitzgerald reiterated its Overweight rating on CVRx, Inc. (NASDAQ:CVRX) on August 17, 2026.
Cantor Fitzgerald reiterated its Overweight rating on CVRx, Inc. (NASDAQ:CVRX) on August 17, 2026.

At publication ·
CVRx, Inc. (NASDAQ:CVRX) · reiterate
At a glance
Cantor Fitzgerald reiterated its Overweight rating on CVRx, Inc. (NASDAQ:CVRX) on August 17, 2026.
CVRx, Inc. operates in the Healthcare sector. The stock currently trades at $2.75 with a market capitalization of $220.4M. The stock has declined 59.0% over the past 52 weeks.
Analyst coverage from Cantor Fitzgerald provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for CVRx, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 10 most recent ratings: 8 Buy, 1 Hold, 1 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 17, 2026 | Cantor Fitzgerald | Overweight | N/A |
| Aug 07, 2026 | Lake Street | Hold | N/A |
| Apr 14, 2026 | Canaccord Genuity | Buy | N/A |
| Feb 13, 2026 | Canaccord Genuity | Buy | N/A |
| Nov 06, 2025 | Canaccord Genuity | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View CVRX Stock Page
A rating of Overweight from Cantor Fitzgerald reflects the analyst's outlook on CVRx, Inc. (NASDAQ:CVRX). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the CVRX forecast page.
Current market data
NASDAQ · CVRX
$2.95
Down: -$0.09 · -2.96%
Live quote updated
Keep reading